Treatment of Preterm Labour–Inhibition of fetal DNA mediated pro-­‐inflammatory immune responses , Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Treatment of Preterm Labour–Inhibition of fetal DNA mediated pro-­‐inflammatory immune responses , Licensing Opportunity from Trinity College Dublin - July 2015

We have made the novel discovery that free foetal DNA sparks off an immune reaction in human cells through a receptor called Toll-like Receptor 9 (TLR-9). In our animal model there is a 69% still birth/inflammation from ...

pdf 1.2MB

Repositioned Nefiracetam: Myelin Repair in Multiple Sclerosis. Licensing opportunity from University College Dublin - August 2015 front page preview

Repositioned Nefiracetam: Myelin Repair in Multiple Sclerosis. Licensing opportunity from University College Dublin - August 2015

Nefiracetam is repositioned as a treatment to promote remyelination in MS. The success of immunomodulator drugs in MS has shifted the discovery focus to remyelination and neuroprotection. The outstanding relief unmet nee...

pdf 369.5KB